Picture of KALA BIO logo

KALA — KALA BIO News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Kala Pharmaceuticals reports Q2 results

Aug 11 (Reuters) - Kala Pharmaceuticals Inc  KALA.O :
    * KALA PHARMACEUTICALS REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES CORPORATE UPDATE
    * KALA PHARMACEUTICALS - BASED ON CURRENT PLANS, ANTICIPATES
CASH
RESOURCES AS OF JUNE 30, 2022, WILL ENABLE IT TO FUND ITS
OPERATIONS INTO Q2 OF 2024
    * KALA PHARMACEUTICALS INC - FOR QUARTER ENDED JUNE 30,
2022, KALA
REPORTED NET PRODUCT REVENUES OF $2.1 MILLION
    * KALA PHARMACEUTICALS INC QTRLY NET LOSS $0.38 PER SHARE

Source text for Eikon:  ID:nGNX7xVvrc 
Further company coverage:  KALA.O

Recent news on KALA BIO

See all news